1
|
Abbas AA, Farghaly TA, Dawood KM. Recent advances on anticancer and antimicrobial activities of directly-fluorinated five-membered heterocycles and their benzo-fused systems. RSC Adv 2024; 14:19752-19779. [PMID: 38899036 PMCID: PMC11185950 DOI: 10.1039/d4ra01387e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2024] [Accepted: 06/05/2024] [Indexed: 06/21/2024] Open
Abstract
Due to the importance of the fluorinated heterocycles as main components of marketed drugs where 20% of the anticancer and antibiotic drugs contain fluorine atoms, this review describes the reported five-membered heterocycles and their benzo-fused systems having directly connected fluorine atom(s). The in vivo and in vitro anticancer and antimicrobial activities of these fluorinated heterocycles are well reported. Some fluorinated heterocycles were found to be lead structures for drug design developments where their activities were almost equal to or exceeded the potency of the reference drugs. In most cases, the fluorine-containing heterocycles showed promising safety index via their reduced cytotoxicity in non-cancerous cell lines. SAR study assigned that fluorinated heterocycles having various electron-donating or electron-withdrawing substituents significantly affected the anticancer and antimicrobial activities.
Collapse
Affiliation(s)
- Ashraf A Abbas
- Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt +202 35727556
| | - Thoraya A Farghaly
- Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt +202 35727556
- Department of Chemistry, Faculty of Science, Umm Al-Qura University Makkah Saudi Arabia
| | - Kamal M Dawood
- Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt +202 35727556
| |
Collapse
|
2
|
Alblewi FF, Alsehli MH, Hritani ZM, Eskandrani A, Alsaedi WH, Alawad MO, Elhenawy AA, Ahmed HY, El-Gaby MSA, Afifi TH, Okasha RM. Synthesis and Characterization of a New Class of Chromene-Azo Sulfonamide Hybrids as Promising Anticancer Candidates with the Exploration of Their EGFR, hCAII, and MMP-2 Inhibitors Based on Molecular Docking Assays. Int J Mol Sci 2023; 24:16716. [PMID: 38069037 PMCID: PMC10706804 DOI: 10.3390/ijms242316716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 11/17/2023] [Accepted: 11/20/2023] [Indexed: 12/18/2023] Open
Abstract
In this study, novel selective antitumor compounds were synthesized based on their fundamental pharmacophoric prerequisites associated with EGFR inhibitors. A molecular hybridization approach was employed to design and prepare a range of 4H-chromene-3-carboxylates 7a-g, 8, and 11a-e derivatives, each incorporating a sulfonamide moiety. The structures of these hybrid molecules were verified using comprehensive analytical and spectroscopic techniques. During the assessment of the newly synthesized compounds for their anticancer properties against three tumor cell lines (HepG-2, MCF-7, and HCT-116), compounds 7f and 7g displayed remarkable antitumor activity against all tested cell lines, outperforming the reference drug Cisplatin in terms of efficacy. Consequently, these promising candidates were selected for further investigation of their anti-EGFR, hCAII, and MMP-2 potential, which exhibited remarkable effectiveness against EGFR and MMP2 when compared to Sorafenib. Additionally, docking investigations regarding the EGFR binding site were implemented for the targeted derivatives in order to attain better comprehension with respect to the pattern in which binding mechanics occur between the investigated molecules and the active site, which illustrated a higher binding efficacy in comparison with Sorafenib.
Collapse
Affiliation(s)
- Fawzia F. Alblewi
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| | - Mosa H. Alsehli
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| | - Zainab M. Hritani
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| | - Areej Eskandrani
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| | - Wael H. Alsaedi
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| | - Majed O. Alawad
- Center of Excellence for Nanomaterials for Clean Energy Applications, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia;
| | - Ahmed A. Elhenawy
- Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City 11884, Egypt; (A.A.E.); (M.S.A.E.-G.)
- Chemistry Department, Faculty of Science and Art, AlBaha University, Al Bahah 65731, Saudi Arabia
| | - Hanaa Y. Ahmed
- The Regional Center for Mycology and Biotechnology, Al-Azhar University, Nasr City 11884, Egypt;
| | - Mohamed S. A. El-Gaby
- Chemistry Department, Faculty of Science, Al-Azhar University, Nasr City 11884, Egypt; (A.A.E.); (M.S.A.E.-G.)
| | - Tarek H. Afifi
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| | - Rawda M. Okasha
- Chemistry Department, College of Science, Taibah University, Medina 30002, Saudi Arabia; (F.F.A.); (Z.M.H.); (A.E.); (W.H.A.)
| |
Collapse
|